跳至主要内容
临床试验/NCT06376357
NCT06376357Enrolling By Invitation不适用

Roles in the Management of Treatment-Induced Peripheral Neuropathy in Cancer Patients Receiving Taxane-Based Chemotherapy and the Effect of Foot Massage on Neuropathy and Quality of Life: A Randomized Controlled Study

Selcuk University2 个研究点 分布在 2 个国家目标入组 54 人开始时间: 2024年4月27日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
54
试验地点
2
主要终点
EORTC QLQ C-30 Quality of Life Scale

研究概览

简要总结

It was aimed to examine the roles in the management of treatment-related peripheral neuropathy in cancer patients receiving taxane-based chemotherapy and the effect of foot massage on neuropathy and quality of life.

详细描述

Intervention Phase of the Research;

  1. Patient information about neuropathy caused by chemotherapy and its management,
  2. Teaching the role application to the patient,
  3. Application process
  4. It will be carried out in 4 steps, including patient monitoring via telemonitoring.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Being registered in the medical oncology outpatient clinic of Selçuk University Faculty of Medicine Hospital
  • Completed standard taxane-based chemotherapy treatment protocol for breast and ovarian cancer
  • Karnofsky Performance Scale being 80 and above (Performance scale of cancer patients)
  • Being 18 years or older
  • Having received at least 3 cycles of taxane-based treatment
  • Presence of grade 2 or higher peripheral neuropathy
  • Being conscious and cooperative
  • Verbal and written approval to participate in the study after an explanation about the study is made.

排除标准

  • Previous skin sensitivity on hands and feet
  • Refused to participate in the study after making a statement about the study
  • Development of peripheral neuropathy due to reasons other than chemotherapy [tumor compression, nutritional disorders, infections or major systemic disease (diabetes mellitus, etc.)]
  • Bone, spine metastasis or malignancy
  • Having mental and psychic problems that would prevent him from taking part in the research.

结局指标

主要结局

EORTC QLQ C-30 Quality of Life Scale

时间窗: 10 minutes

Quality of life of patients will be evaluated with EORTC QLQ-C30, which was developed by EORTC for cancer patients and is widely used all over the world.

Pain Threshold Assessment Test

时间窗: 5 minutes

algometer (Baseline, USA) will be used. The Algometer (Relevant material is located in Selçuk University SHMYO application laboratory and it is planned to be taken and used with a report for the study and returned after the last measurements) is positioned upright and the pressure is increased to 1kg/cm2 at the painful point every three seconds and the measurements are taken with a 30-second rest period in between. It is applied 3 times and the average of 3 measurements is used for analysis.

Brief Pain Inventory BPI

时间窗: 5 minutes

The BPI questionnaire is a short, easy-to-apply assessment method that can be used to evaluate pain and related functions (general activity, walking ability, normal work, relationships with other people, sleep, enjoyment of life). It includes simple 0 to 10 numerical rating scales that are both easy to understand and easy to translate into different languages. In the short pain inventory, the mildest pain score = 0 and the most severe pain score = 10.

Two Point Discrimination

时间窗: 10 minutes

Evaluation will be made from the trans-metatarsal area, middle of the foot and middle of the heel. It will start from the interval where two points can be easily distinguished. The distance between two points will be reduced in 1 mm intervals until the two points are felt as a single point. Then, it will start with two-point stimulation at the minimum interval felt as a single point, and the distance between the two points will be increased in 1 mm intervals until the distance between the two points is felt separately as two points again.

CIPN20 Neuropathy Scale

时间窗: 10 minutes

It is a 20-item assessment tool used to reveal the symptoms of chemotherapy-related peripheral neuropathy and the impact of functional limitations caused by this problem on patients' lives.

One Leg Standing Test

时间窗: 5 minutes

The Single Leg Standing Test (TAUDT), which is widely used to evaluate static balance, is a simple test that can be used in many situations and requires minimal equipment.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ülkü Saygılı

Assist. Prof

Selcuk University

研究点 (2)

Loading locations...

相似试验

进行中(未招募)
不适用
Evaluation of Therapeutic Footwear on the foot of people with Diabetes Mellitusdiabetic polyneuropathyC23.550.291.500Diabetes Mellitus
RBR-3z667w2niversidade Federal de São Paulo - Escola paulista de Enfermagem
已完成
3 期
Treatment of Peripheral Neuropathy in Patients With DiabetesDiabetic NeuropathiesDiabetes Mellitus
NCT00044421Eli Lilly and Company400
尚未招募
不适用
Interventtion study for peripheral neuropathy derived from chemotherapy. Effectiveness of green bamboo stepping for sole.cancer
JPRN-UMIN000035424shinshu univarsity school of medicine10
进行中(未招募)
不适用
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Lung Non-Small Cell CarcinomaPrognostic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8Prognostic Stage IIIC Breast Cancer AJCC v8Stage I Lung Cancer AJCC v8Stage I Ovarian Cancer AJCC v8Stage IA Ovarian Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage IB Ovarian Cancer AJCC v8Stage IC Ovarian Cancer AJCC v8Stage II Lung Cancer AJCC v8Stage II Ovarian Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIA Ovarian Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage IIB Ovarian Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage III Ovarian Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIA Ovarian Cancer AJCC v8Stage IIIA1 Ovarian Cancer AJCC v8Stage IIIA2 Ovarian Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIB Ovarian Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IIIC Ovarian Cancer AJCC v8
NCT03939481SWOG Cancer Research Network1,336
已完成
不适用
Nurse-led Pain Education Clinical Trial in Chronic Pain PatientsPain, Chronic
NCT05482152Universiteit Antwerpen39